- Home
- Free App Analytics
- MedLinc
- MedLinc Vs. 中抗头条
MedLinc vs 中抗头条 Usage & Stats
MedLinc is one of the largest professional networks for healthcare providers worldwide. It empowers its healthcare professional users to connect, communicate and collaborate with one another. As an accomplished healthcare professional, you can further build your international influence and brand recognition through MedLinc by sharing your knowledge and expertise to a large audience globally, including but not limited to giving webinars online and/or talks at numerous hospitals in China face-to-face, and receiving consulting project opportunities domestically & internationalluy, etc. MedLinc also provides healthcare institutions to share latest innovations and breakthroughs, top journal publications, first-class training programs, and key speciality updates, to over 3.5 million physicians and 30 thousand hospitals in China, so as to gain best collaborative opportunities and attract international patients.
Disclaimer
1. All information on this software is for your reference only, and should not be used as the basis for diagnosis or medication, nor can it replace the advice of doctors and other medical personnel. As a medical social platform, this software is committed to providing medical information as accurate and complete as possible, but does not guarantee the correctness and completeness of the information, and is not responsible for any loss or damage caused by inaccuracy or omission of information. Any accident, loss or damage caused by you shall be your responsibility, and this software shall not be held responsible, nor shall it bear any direct, indirect, special, joint and several legal liabilities. Information could be out of date and the software makes no commitment to update them.
2. Whether you accept the remarks and information (including but not limited to articles, pictures, etc.) published by other users, or conducts certain actions based on the remarks and information published by other users, is purely your own decision. You are solely responsible for your decisions and actions, and the software platform is not responsible for it.
3. You are solely responsible for the authenticity, legality and validity of the information you publish on this software, and this software does not assume any guarantee or guarantee responsibility for the information you publish.
4. After you register as a user of this software, you are responsible for keeping your account and password. You are solely responsible for all activities and events with your account, provided you have the right to change your password at any time as directed.
5. This software is exempt from any personal data leakage, loss, theft or tampering caused by force majeure such as hacker attack, computer virus intrusion or outbreak, temporary shutdown due to government control, etc. that affect the normal operation of the network.
6. Except for the terms of service indicated in this software, any other accident, negligence, defamation, copyright or intellectual property infringement caused by the use of this software and the resulting losses (including infection of mobile phone viruses due to downloading), this software We do not assume any responsibility.
7. This software is exempt from any personal data leakage caused by other third-party software or third-party web pages linked to this software and any legal disputes and consequences arising therefrom.
8. The software can be updated, upgraded or closed without your consent. You can stop using the software at any time without special notice to the platform.
- Apple App Store
- Free
- Medical
Store Rank
- -
中抗头条是癫痫垂直领域的资讯、交流、服务平台,官方唯一认证的平台。
携手抗痫,健康中国
提供行业最新资讯,发布协会权威报道,建立医生,医院之间的学术交流。
- Apple App Store
- Free
- Health & Fitness
Store Rank
- -
MedLinc vs. 中抗头条 ranking comparison
Compare MedLinc ranking trend in the past 28 days vs. 中抗头条
Rank
No Data Available
MedLinc vs. 中抗头条 ranking by country comparison
Compare MedLinc ranking trend in the past 28 days vs. 中抗头条
No Data to Display
Compare to any site with our free trial
January 15, 2026